Fifth Third Bancorp
ATRA icon

Fifth Third Bancorp’s Atara Biotherapeutics ATRA Stock Holding History

Fifth Third Bancorp’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-4
Closed -$3K – 2732
2015
Q3 		$3K Hold
4
– – ﹤0.01% 2452
2015
Q2 		$5K Buy
+4
New +$4.59K ﹤0.01% 2282

Other funds holding ATRA

Baupost Group
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Eagle Asset Management
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ArrowMark Colorado Holdings
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fifth Third Bancorp's ATRA Position: Q4 2015 in Review

Fifth Third Bancorp sold out of Atara Biotherapeutics (ATRA) in Q4 2015, closing a stake of 4 shares — an estimated $3K sold.

Fifth Third Bancorp first reported a position in ATRA in Q2 2015 and held it in 2 quarters. The position peaked at $5K in Q2 2015. 85 funds tracked by Wall St. Rank hold ATRA as of Q4 2015.

  • Fifth Third Bancorp reported no remaining Atara Biotherapeutics position as of Q4 2015 after selling out during the quarter.
  • Fifth Third Bancorp sold 4 Atara Biotherapeutics shares in Q4 2015, an estimated $3K.
  • Fifth Third Bancorp first reported a position in Atara Biotherapeutics in Q2 2015 and held it in 2 quarters.
  • Fifth Third Bancorp's Atara Biotherapeutics position peaked at $5K in Q2 2015.
  • 85 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q4 2015.

Based on Fifth Third Bancorp's 13F filing for Q4 2015, filed 16 Feb 2016.